Login / Signup
Pembrolizumab as first-line therapy in programmed death ligand 1-positive advanced lung cancer: Is it as effective as we think it is?
Daniel A Goldstein
Usama Bilal
Vinay Prasad
Published in:
Cancer (2017)
Keyphrases
</>
advanced non small cell lung cancer
stem cells